AbstractTriple-negative breast cancer (TNBC) remains one of the most lethal breast cancer subtypes dueto its high metastatic potential and lack of targeted therapies. While oncogenic drivers of metast
Accumulating evidence has shown the existence of tumor stem cells, and many researchers and clinicians are focusing on the therapeutic potential of targeting tumor stem cells. Previously, we reported
Human prostate CWR22 OT-tumor cells were prospectively purified for expression of various stem cell markers (TRA-1-60/CD151/CD166/EpCAM/CD44/α2-Integrin). Unsorted total tumor cells or the additional